What are the individual perceptions of patients with borderline tumours of the ovary in regard to pathogenesis and prognosis? A structured survey on 60 women

References

• Skirnisdottir I, Garmo H, Wilander E, Holmberg L. Borderline ovarian tumours in Sweden 1960–2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer 2008;123:1897–1901.
   PubMed Web of Science ®Google Scholar
• Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Pecorelli S, Beller U. Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006;95 (Suppl 1): S161–S192.
   Web of Science ®Google Scholar
• Kurman RJ, Shih IeM. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010;34:433–443.
   PubMed Web of Science ®Google Scholar
• International Federation of Gynecology and Obstetrics. Changing in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 1987;156:263–264.
   Google Scholar
• Barnhill DR, Kurman RJ, Brady MF, Omura GA, Yordan E, Given FT, Kucera PR, Roman LD. Preliminary analysis of the behavior of stage I ovarian serous tumours of low malignant potential: a Gynecologic Oncology Group study. J Clin Oncol 1995;13:2752–2756.
   PubMedGoogle Scholar
• Fotopoulou C, Schumacher G, Schefold JC, Denkert C, Lichtenegger W, Sehouli J. Systematic evaluation of the intraoperative tumour pattern in patients with borderline tumour of the ovary. Int J Gynecol Cancer 2009;19:1550–1555.
   Google Scholar
• Winter WE III, Kucera PR, Rodgers W, McBroom JW, Olsen C, Maxwell GL. Surgical staging in patients with ovarian tumours of low malignant potential. Obstet Gynecol 2002;100:671–676.
   PubMed Web of Science ®Google Scholar
• Bradburn NM, Sudburn S, Wansink B. Asking questions: the definitive guide to questionnaire design. San Francisco, CA: Jossey-Bass; 2004.
   Google Scholar
• Czaja R, Blair J. Designing surveys: a guide to decisions and procedures. Thousand Oaks, CA: Sage Publications; 2005.
   Google Scholar
• Fowler FJ. Survey research methods. 3rd ed. Thousand Oaks, CA: Sage Publications; 2002.
   Google Scholar
• Fowler FJ. Improving survey questions: design and evaluation. Thousand Oaks, CA: Sage Publications; 1995.
   Google Scholar
• Peterson R. Constructing effective questionnaires. Thousand Oaks, CA: Sage Publications; 2000.
   Google Scholar
• Prat J, De Nictolis M. Serous borderline tumours of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 2002;26:1111–1128.
   PubMed Web of Science ®Google Scholar
• Ronnett BM, Kajdacsy-Balla A, Gilks CB, Merino MJ, Silva E, Werness BA, Young RH. Mucinous borderline ovarian tumours: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol 2004;35:949–960.
   PubMed Web of Science ®Google Scholar
• Chiesa AG, Deavers MT, Veras E, Silva EG, Gershenson D, Malpica A. Ovarian intestinal type mucinous borderline tumours: are we ready for a nomenclature change? Int J Gynecol Pathol 2010;29:108–112.
   Google Scholar
• Tropé C, Davidson B, Paulsen T, Abeler VM, Kaern J. Diagnosis and treatment of borderline ovarian neoplasms “the state of the art”. Eur J Gynaecol Oncol 2009;30:471–482.
   Google Scholar
• Yokoyama Y, Moriya T, Takano T, Shoji T, Takahashi O, Nakahara K, Yamada H, Yaegashi N, Okamura K, Izutsu T, et al. Clinical outcome and risk factors for recurrence in borderline ovarian tumours. Br J Cancer 2006;94:1586–1591.
   Google Scholar
• Oskay-Özcelik G, Neubert S, Münstedt K, Liebrich C, Hanker LC, Lorenz R, Wimberger P, Mahner S, Hindenburg H, Sehouli J. What do primary and recurrent ovarian cancer patients (OC) expect from their doctors? Final results of a German survey in 608 patients. J Clin Oncol 2010;28: 15s (suppl; abstr 5106).
   Google Scholar
• Coumbos A, Sehouli J, Chekerov R, Schaedel D, Oskay-Oezcelik G, Lichtenegger W, Kuehn W; North-Eastern German Society of Gynecological Oncology (NOGGO). Clinical management of borderline tumours of the ovary: results of a multicentre survey of 323 clinics in Germany. Br J Cancer 2009;100:1731–1738.
   PubMed Web of Science ®Google Scholar
• Elit L, Charles C, Dimitry S, Tedford-Gold S, Gafni A, Gold I, Whelan T. It's a choice to move forward: women's perceptions about treatment decision making in recurrent ovarian cancer. Psychooncology 2010;19:318–325.
   PubMed Web of Science ®Google Scholar
• Elit L, Charles C, Gold I, Gafni A, Farrell S, Tedford S, Dal Bello D, Whelan T. Women's perceptions about treatment decision making for ovarian cancer. Gynecol Oncol 2003;88:89–95.
   Web of Science ®Google Scholar